Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...

Researchers have unlocked a powerful new way to fight solid tumors using smart immune cells that stay active longer and hit ...

LEHIGH VALLEY, Pa. - American Cancer Society had some special guests at Saturday's telethon fundraiser. Two guests were ...

Axi-cel, tisa-cel, and brexu-cel were found comparable to other cellular therapy experiences for patients with B-cell ...

Discover the long-term results of CAR T-cell therapy, with and without stem cell transplantation, for relapsed lymphoma ...

The national conclave, Cura Immunis, organised by the Medical Trust Hospital, Kochi, was inaugurated by Divya S. Iyer, ...

Researchers proposed changing the recommendations for universal driving restrictions after CAR T-cell infusion.

Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their investigational new drug (IND) application to study ...